We design and develop a new class of powerful therapeutics for the treatment of severe diseases. Our plug-and-play platform substantially reduces the random nature of the discovery process to predictably yield ready-to-develop multispecific biotherapeutics for chronic inflammation and cancer.

Cooperation possibilities

Numab offers its discovery and development capabilities to industry partners who are looking for innovative antibody-based products. For further information please contact partnering@numab.com.

Location

Einsiedlerstrasse 34, 8820 Wädenswil, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2011

  • Number of employees in Switzerland

    20-49

Key business